An implantable system for opioid safety Huang, Hen-Wei et al. Device, Volume 0, Issue 0, 100517  https://www.cell.com/device/fulltext/S2666-9986(24)00417-4https://www.cell.com/device/fulltext/S2666-9986(24)00417-4

Implantat stoppt Opiatüberdosierung innerhalb weniger Minuten Cambridge/Massachusetts – US-Ingenieure haben ein Implantat entwickelt, das eine Opiatüberdosierung erkennen und automatisch durch die Injektion von Naloxon beenden kann. Der Publikation…

USA. FDA Approves First Nalmefene Hydrochloride Auto-Injector to Reverse Opioid Overdose Agency Continues to Support Development of Overdose Reversal Drugs including Naloxone and Nalmefene. (FDA – Federal Drug Administation, USA, 08.07.2024) https…

Narcanazo: Community Activation of Antiracist Epidemiology.  Oyola-Santiago T, Gelpí-Acosta C, Aponte-Meléndez Y, Cano M.  Am J Public Health. 2024 Jul;114(S6):S463-S466. doi: 10.2105/AJPH.2024.307605. PMID: 39083738; PMCID: PMC11292290…

Adding newly identified compound makes naloxone more potent, longer lasting, mouse study shows The ongoing opioid epidemic in the U.S. kills tens of thousands of people every year. Naloxone, sold under the brand name Narcan, has saved countless liv…

FDA Approves Risky Opioid Overdose Reversal Product From Purdue Pharma On August 7 the Food and Drug Administration approved an opioid overdose antidote developed by Purdue Pharma that contains nalmefene, as opposed to the better-known naloxone. Zu…